Human Immunodeficiency Virus (HIV) Epidemiology in 9 Countries and Forecasts to 2023

News provided by

Oct 13, 2015, 01:30 ET

PUNE, India, October 13, 2015 /PRNewswire/ --

Market research titled EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2023 segments total prevalent cases of HIV by age and sex using country-specific data, whenever available; when data were not available, appropriate proxies were used.

Complete report on HIV epidemiology spread across 65 pages, analyzing 9 major markets and supported with 17 tables and 10 figures is now available at http://www.lifescienceindustryresearch.com/epicast-report-human-immunodeficiency-virus-hiv-epidemiology-forecast-to-2023.html .

For Japan, epidemiologists provide an alternative forecast for the 20-year diagnosed prevalent cases of HIV in this HIV epidemiology research, which better aligns with the ART market sales data after consolidation. Epidemiologists also provide an alternative forecast for Japan, based on the reported HIV prevalent cases. In 2013, there were 3,394,507 total prevalent cases of HIV in the 8MM, with 1,218,323 cases in the US and 641,500 in the 5EU markets combined. Japan had 18,428 20-year diagnosed prevalent cases of HIV in 2013. Epidemiologists forecast that the total prevalent cases of HIV in the 8MM will increase to 4,126,502 in the 8MM by 2023. Additionally, epidemiologists forecast that the 20-year diagnosed prevalent cases of HIV in Japan will increase to 27,264 cases by 2023.

The 2015 HIV Epidemiology Report with Forecasts to 2023 provides an overview of the risk factors, comorbidities, and global trends for HIV in the nine major markets (9MM) (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and China). It includes a 10-year epidemiological forecast of the total prevalent cases of HIV segmented by sex and age (beginning at 0 years and ending at =85 years) in the 8MM, excluding Japan, for which 20-year diagnosed prevalent cases, is forecast. In addition, the report provides the prevalent cases of HIV-positive pregnant women in the total prevalent HIV cases, as well as the total prevalent cases treated by antiretroviral drugs. The HIV epidemiology report is written and developed by Masters and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

This HIV epidemiology market research aims to help develop business strategies by understanding the trends shaping and driving the global HIV market. It also helps quantify patient populations in the global HIV market to improve product design, pricing, and launch plans as well as organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for HIV therapeutics in each of the markets covered. Order a copy of EpiCast Report: Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2023 at http://www.lifescienceindustryresearch.com/purchase?rname=58902 .

Tables provided in this HIV epidemiology report cover:

Risk Factors and Comorbidities for HIV 11
US, Total Prevalence of HIV in Men and Women (%), Ages ?13 Years, 2006-2010 13
5EU, Total Prevalence of HIV in Men (%), All Ages, Selected Years, 2001-2013 14
5EU, Total Prevalence of HIV in Women (%), All Ages, Selected Years, 2001-2013 14
8MM, Sources Used to Forecast the Total Prevalent Cases of HIV 16
Japan, Sources Used to Forecast the 20-Year Diagnosed Prevalent Cases of HIV in Japan 17
9MM, Sources Used to Forecast the ART Treatment Rate Among the Total Prevalent Cases of HIV 18
9MM, Sources Used to Forecast the Prevalent Cases of HIV-Positive Pregnant Women 20
8MM, Total Prevalent Cases of HIV, Men and Women, All Ages, N, Selected Years, 2013-2023 34
8MM, Age-Specific Total Prevalent Cases of HIV, Men and Women, N (Row %), 2013 36
8MM, Sex-Specific Total Prevalent Cases of HIV, All Ages, N (Row %), 2013 38
8MM, HIV Cases Treated with ART, N (Col %), All Ages, Both Sexes, Selected Years 2013-2023 41
Japan, 20-Year Diagnosed Prevalent Cases of HIV, Men and Women, All Ages, N, Selected Years, 2013-2023 43
Japan, Age-Specific 20-Year Diagnosed Prevalent Cases of HIV, Men and Women, N (Row %), 2013 44
Japan, Sex-Specific 20-Year Diagnosed Prevalent Cases of HIV, All Ages, N (Row %), 2013 45
Japan, HIV Cases Treated with ART, All Ages, Both Sexes, N, Selected Years 2013-2023 47
High-Prescribing Physicians (non-KOLs) Surveyed, by Country 59

On a related note, explore more reports available on HIV diagnostics market (global and regional) as well as other HIV related reports at http://www.lifescienceindustryresearch.com/?s=HIV .

Other newly published research and reports on pharmaceuticals market are available at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

About Us:

LifeScienceIndustryResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
[email protected]

Connect with Us:

G+ / Google Plus: https://plus.google.com/112612135957880308475/about

Twitter: https://twitter.com/LifeSciReports

RSS / Feeds: http://www.lifescienceindustryresearch.com/feed/

SOURCE Life Science Industry Research